Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMID 11493046)

Published in Prev Med on August 01, 2001

Authors

A M Codori1, G M Petersen, D L Miglioretti, P Boyd

Author Affiliations

1: Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA. acodori@mail.jhmi.edu

Articles citing this

Individual-level factors in colorectal cancer screening: a review of the literature on the relation of individual-level health behavior constructs and screening behavior. Psychooncology (2010) 1.43

Using family history information to promote healthy lifestyles and prevent diseases; a discussion of the evidence. BMC Public Health (2010) 1.42

Factors associated with colorectal cancer screening among the US urban Japanese population. Am J Public Health (2004) 1.36

Perspectives of colorectal cancer risk and screening among Dominicans and Puerto Ricans: stigma and misperceptions. Qual Health Res (2009) 1.16

Factors associated with intentions to adhere to colorectal cancer screening follow-up exams. BMC Public Health (2006) 1.10

Computer-delivered tailored intervention improves colon cancer screening knowledge and health beliefs of African-Americans. Health Educ Res (2012) 1.06

Racial differences in use of colonoscopy, sigmoidoscopy, and barium enema in Medicare beneficiaries. Dig Dis Sci (2002) 1.02

Motivation for health screening: evaluation of social influence among Mexican-American adults. Am J Prev Med (2010) 1.00

Does colorectal cancer risk perception predict screening behavior? A systematic review and meta-analysis. J Behav Med (2015) 0.96

Changes in risk perceptions in relation to self-reported colorectal cancer screening among first-degree relatives of colorectal cancer cases enrolled in a randomized trial. Health Psychol (2011) 0.96

Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis. Fam Cancer (2013) 0.96

A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients. BMC Cancer (2013) 0.91

Gender differences in attitudes impeding colorectal cancer screening. BMC Public Health (2013) 0.90

Colonoscopy screening among US adults aged 40 or older with a family history of colorectal cancer. Prev Chronic Dis (2015) 0.89

Family history of colorectal cancer: clinicians' preventive recommendations and patient behavior. Prev Chronic Dis (2011) 0.89

The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families. Contemp Clin Trials (2011) 0.87

Risk perception among Brazilian individuals with high risk for colorectal cancer and colonoscopy. Hered Cancer Clin Pract (2011) 0.84

Modeling pathways to affective barriers on colorectal cancer screening among Japanese Americans. J Behav Med (2005) 0.83

Determinants of participation in colonoscopic screening by siblings of colorectal cancer patients in France. BMC Cancer (2010) 0.82

Association of health beliefs and colonoscopy use among survivors of colorectal cancer. J Cancer Surviv (2009) 0.82

No association between colorectal cancer worry and screening uptake in Appalachian Ohio. J Public Health (Oxf) (2014) 0.82

Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. Cancer Epidemiol Biomarkers Prev (2009) 0.81

Disgusted, embarrassed, annoyed: affective associations relate to uptake of colonoscopy screening. Ann Behav Med (2014) 0.81

Family Support and Colorectal Cancer Screening among Urban African Americans. J Nurse Pract (2012) 0.79

Interactions among physicians, patients, and first-degree relatives in the familial screening of colorectal cancer in France. Patient Prefer Adherence (2008) 0.79

Perceived versus predicted risks of colorectal cancer and self-reported colonoscopies by members of mismatch repair gene mutation-carrying families who have declined genetic testing. J Genet Couns (2013) 0.78

Predictors of colonoscopy use one year after colonoscopy: prospective study of surveillance behavior for colorectal cancer. Health Psychol Behav Med (2014) 0.76

A Process Evaluation of the Alaska Native Colorectal Cancer Family Outreach Program. Health Educ Behav (2015) 0.75

A comparison of colorectal cancer screening uptake among average-risk insured American Indian/Alaska Native and white women. J Health Care Poor Underserved (2013) 0.75

Development and Psychometric Evaluation of the Lung Cancer Screening Health Belief Scales. Cancer Nurs (2016) 0.75

Rural-Urban Differences in Colorectal Cancer Screening Barriers in Nebraska. J Community Health (2015) 0.75

Concern and risk perception: effects on osteoprotective behaviour. J Osteoporos (2014) 0.75

Articles by these authors

Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet (2001) 6.36

Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology (2000) 5.40

Functional mapping of human sensorimotor cortex with electrocorticographic spectral analysis. II. Event-related synchronization in the gamma band. Brain (1998) 5.36

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86

The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med (1997) 4.66

Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med (1986) 4.18

Molecular diagnosis of familial adenomatous polyposis. N Engl J Med (1993) 4.07

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res (1996) 3.60

Functional mapping of human sensorimotor cortex with electrocorticographic spectral analysis. I. Alpha and beta event-related desynchronization. Brain (1998) 3.26

The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25

Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07

A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol (2008) 2.97

AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology (2001) 2.63

Lung cancer in nonsmoking women: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev (1993) 2.53

hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39

The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet (2004) 2.10

Desmoid tumours in familial adenomatous polyposis. Gut (1994) 2.08

Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study. JAMA (1994) 2.04

Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1995) 2.02

Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98

Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut (1996) 1.89

Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology (2000) 1.86

Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut (1998) 1.85

Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology (1989) 1.80

Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1996) 1.75

Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res (1998) 1.73

Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology (1989) 1.63

Duodenal atresia: associated anomalies, prenatal diagnosis and outcome. Pediatr Surg Int (2009) 1.61

Dimensions of oral-health-related quality of life. J Dent Res (2004) 1.55

Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut (2004) 1.55

Familial pancreatic cancer. Cancer J (2001) 1.51

Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology (1994) 1.48

Prevalence of congenital anomalies in five British regions, 1991-99. Arch Dis Child Fetal Neonatal Ed (2005) 1.48

Brief bursts of pulse stimulation terminate afterdischarges caused by cortical stimulation. Neurology (1999) 1.45

Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial. Ann Intern Med (1994) 1.45

How accurate are bedside hearing tests? Neurology (2007) 1.43

On the aggregation of meso-substituted water-soluble porphyrins. J Am Chem Soc (1972) 1.40

Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35

Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol (2002) 1.34

Use of coping strategies and breast cancer survival: results from the Black/White Cancer Survival Study. Am J Epidemiol (2000) 1.33

Familial pancreatic cancer. Ann Oncol (1999) 1.33

Chilling, oxidative stress and antioxidant responses in Arabidopsis thaliana callus. Planta (1996) 1.32

Screening for germ-line mutations in familial adenomatous polyposis patients: 61 new patients and a summary of 150 unrelated patients. Hum Mutat (1992) 1.30

Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.29

Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency. Am J Med Genet (1989) 1.29

Phenotypic expression of disease in families that have mutations in the 5' region of the adenomatous polyposis coli gene. Ann Intern Med (1997) 1.29

MUC-2 human small intestinal mucin gene structure. Repeated arrays and polymorphism. J Clin Invest (1991) 1.26

Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev (1999) 1.26

A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil (2007) 1.23

The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin. Am J Hum Genet (1983) 1.22

Prenatal diagnosis of an epignathus: a case report and review of the literature. Ultrasound Obstet Gynecol (2001) 1.21

Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil (2008) 1.19

Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.10

Adolescents--drug abuse and addiction. Br Med J (1972) 1.08

Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychol (1997) 1.07

Direct milk excretion of Campylobacter jejuni in a dairy cow causing cases of human enteritis. Epidemiol Infect (1995) 1.06

NIH consensus development statement on management of hepatitis B. NIH Consens State Sci Statements (2009) 1.06

Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC? Fam Cancer (2001) 1.06

Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma. Gut (2005) 1.05

Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am (1998) 1.05

Differential immunity in pigs with high and low responses to porcine reproductive and respiratory syndrome virus infection. J Anim Sci (2007) 1.04

Relationships between the human pepsinogen DNA and protein polymorphisms. Am J Hum Genet (1986) 1.03

Short-term consistency in self-reported physical functioning among elderly women: the Women's Health and Aging Study. Am J Epidemiol (1998) 1.02

Analysis of masked mutations in familial adenomatous polyposis. Proc Natl Acad Sci U S A (1999) 1.01

Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology (1993) 1.00

A new vision of ocean biogeochemistry after a decade of the Joint Global Ocean Flux Study (JGOFS). Ambio (2001) 0.99

Risk factors for gallstone formation during rapid loss of weight. Dig Dis Sci (1992) 0.99

Genetic testing for cancer in children. Short-term psychological effect. Arch Pediatr Adolesc Med (1996) 0.98

Treatment and follow-up of adolescents addicted to heroin. Br Med J (1971) 0.97

Sex differences in recombination fraction estimates and their effect on ordering of chromosome 11 markers. Genet Epidemiol Suppl (1986) 0.96

APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut (1997) 0.95

A study of contemporary levels and temporal trends in inbreeding in the Tangier Island, Virginia, population using pedigree data and isonymy. Am J Phys Anthropol (2000) 0.94

Evidence against genetic anticipation in familial colorectal cancer. Genet Epidemiol (1997) 0.92

Historical cohort investigation of spontaneous abortion in the Semiconductor Health Study: epidemiologic methods and analyses of risk in fabrication overall and in fabrication work groups. Am J Ind Med (1995) 0.91

Documenting the effect and cost of public health nursing field services. Public Health Nurs (1987) 0.90

An aetiological classification of birth defects for epidemiological research. J Med Genet (2005) 0.88

Genetic factors in Haemophilus influenzae type b disease susceptibility and antibody acquisition. J Pediatr (1987) 0.88

Temporal dynamics of verbal object comprehension. Proc Natl Acad Sci U S A (1998) 0.88

Letter of retraction. Prenat Diagn (1990) 0.87

Heroin addiction in adolescents. J Psychosom Res (1970) 0.87

Postnatal outcome of antenatally diagnosed intra-abdominal cysts. Pediatr Surg Int (2008) 0.86

Overview of the Second International Workshop to define swine cluster of differentiation (CD) antigens. Vet Immunol Immunopathol (1998) 0.85

Identification and semi-quantitation of Ostertagia ostertagi eggs by enzymatic amplification of ITS-1 sequences. Vet Parasitol (1998) 0.84

Influenza vaccine efficacy in a Maryland nursing home. Md Med J (1988) 0.84

The APC E1317Q variant in adenomatous polyps and colorectal cancers. Cancer Epidemiol Biomarkers Prev (2003) 0.84

Support for chromatin acidic proteins as acceptors for progesterone in the chick oviduct. J Steroid Biochem (1979) 0.83

The outcome of public health nursing service in a preventive child health program: phase 1, health assessment. Public Health Nurs (1988) 0.83

Uridine monophosphate kinase 3: a genetic marker for susceptibility to Haemophilus influenzae type B disease. Lancet (1985) 0.82

Report on the analyses of mAb reactive with porcine CD8 for the second international swine CD workshop. Vet Immunol Immunopathol (1998) 0.82

High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation (1995) 0.82

Pepsinogens and other physiologic markers in genetic studies of peptic ulcer and related disorders. Prog Clin Biol Res (1985) 0.82

Normal superoxide dismutase (SOD) gene in pregnancy-induced hypertension: is the decreased SOD activity a secondary phenomenon? Free Radic Res (1994) 0.81

Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells. Biotechnol Bioeng (2001) 0.81

Genetic marker family studies in familial Mediterranean fever (FMF) in Armenians. Clin Genet (1990) 0.80

Serum amyloid A and P protein genes in familial Mediterranean fever. Genomics (1990) 0.80

Correlations between microbial parameters from water samples: expectations and reality. Water Sci Technol (2001) 0.80

Cochlear reimplantation. Ann Otol Rhinol Laryngol Suppl (1995) 0.79

Class and subclass antibodies to Haemophilus influenzae type b capsule: comparison of invasive disease and natural exposure. Infect Immun (1986) 0.79